RecruitingN/A

Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

NCT07187479

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Arizona Kidney Disease and Hypertension Center

Phoenix, Arizona, United States

Contact

Richard Marchase, PhD